Veeva Systems (VEEV) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $2.35
- Estimate
- $2.22
- Surprise
- +5.8%
- Revenue (period 2026-07-31)
- $928.0M
- Score at report (before → after)
- 5.9 → 6.3/10
Revenue source: xbrl.
How the report landed
Veeva Systems (VEEV) beat the $2.22 estimate with diluted EPS of $2.35 — a clear 5.8% upside surprise. TrendMatrix's engine moved from Hold (5.9/10) to Buy (Wait) at 6.3/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates VEEV Buy (Wait) at 6.6/10.
4 of the last 4 quarters beat the estimate; this quarter's +5.8% surprise compares with a +5.4% four-quarter average. Next scheduled report: 2026-11-25.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.4 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Geographic: North America
- Analyst target reached - limited upside remaining
- Expensive valuation
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $281.00
- Entry target
- $228.84
- Price target
- $290.32
- Stop
- $205.92
- Upside to target
- +3.3%
The stock trades at 46.1× trailing but 27.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 73 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
VEEV at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $46.04B
- P/E (fwd)
- 27.8
- P/E (ttm)
- 46.1
- 52-week range
- $148.05–$310.50
- Off 52-week high
- 9.5%
- RSI (14)
- 73
- Volume vs avg
- 0.75×
- Score today
- 6.6/10